1.
Service Overview
2.
Research Methodology
3.
Executive Summary
4.
Impact of COVID-19 on Global Lung Cancer Genomic Testing
Market
5.
Voice of Customer
5.1. Lung Cancer
Prevalence, By Type
5.2. Lung Cancer
Prevalence, By Gender
5.3. Lung Cancer
Prevalence, By Age Group
5.4. Lung Cancer
Prevalence, By Region
5.5. Causes of Lung
Cancer
6.
Clinical Trial Analysis
7.
Patent Analysis
8. Global Lung Cancer
Genomic Testing Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Component (Products v/s Services)
8.2.2.
By Technology (Next Generation Sequencing, Polymerase
Chain Reactions, Fluorescence In Situ Hybridization (FISH)/In Situ
Hybridization (ISH), Others)
8.2.3.
By Panel Type (Single Panel v/s Multi-Gene Panel)
8.2.4.
By Sample Type (Tissue Biopsy v/s Liquid Biopsy)
8.2.5.
By End User (Academic & Research Institutions,
Hospitals & Clinics, Diagnostic Laboratories, Others)
8.2.6.
By Company (2021)
8.2.7. By
Region
8.3.
Product Market Map
9. North America Lung
Cancer Genomic Testing Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Component
9.2.2.
By Technology
9.2.3.
By Panel Type
9.2.4.
By Sample Type
9.2.5.
By End User
9.2.6.
By Country
9.3.
Policy & Regulatory Landscape
9.4.
North America: Country Analysis
9.4.1.
United States Lung Cancer Genomic Testing
Market Outlook
9.4.1.1.
Market Size & Forecast
9.4.1.1.1.
By Value
9.4.1.2.
Market Share & Forecast
9.4.1.2.1.
By Component
9.4.1.2.2.
By Technology
9.4.1.2.3.
By Panel Type
9.4.1.2.4.
By Sample Type
9.4.1.2.5.
By End User
9.4.2.
Mexico Lung Cancer Genomic Testing Market Outlook
9.4.2.1.
Market Size & Forecast
9.4.2.1.1.
By Value
9.4.2.2.
Market Share & Forecast
9.4.2.2.1.
By Component
9.4.2.2.2.
By Technology
9.4.2.2.3.
By Panel Type
9.4.2.2.4.
By Sample Type
9.4.2.2.5.
By End User
9.4.3.
Canada Lung Cancer Genomic Testing Market Outlook
9.4.3.1.
Market Size & Forecast
9.4.3.1.1.
By Value
9.4.3.2.
Market Share & Forecast
9.4.3.2.1.
By Component
9.4.3.2.2.
By Technology
9.4.3.2.3.
By Panel Type
9.4.3.2.4.
By Sample Type
9.4.3.2.5.
By End User
10. Europe Lung Cancer
Genomic Testing Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Component
10.2.2.
By Technology
10.2.3.
By Panel Type
10.2.4.
By Sample Type
10.2.5.
By End User
10.2.6.
By Country
10.3.
Policy & Regulatory Landscape
10.4.
Europe: Country Analysis
10.4.1.
France Lung Cancer Genomic Testing Market Outlook
10.4.1.1.
Market Size & Forecast
10.4.1.1.1.
By Value
10.4.1.2.
Market Share & Forecast
10.4.1.2.1.
By Component
10.4.1.2.2.
By Technology
10.4.1.2.3.
By Panel Type
10.4.1.2.4.
By Sample Type
10.4.1.2.5.
By End User
10.4.2.
Germany Lung Cancer Genomic Testing Market Outlook
10.4.2.1.
Market Size & Forecast
10.4.2.1.1.
By Value
10.4.2.2.
Market Share & Forecast
10.4.2.2.1.
By Component
10.4.2.2.2.
By Technology
10.4.2.2.3.
By Panel Type
10.4.2.2.4.
By Sample Type
10.4.2.2.5.
By End User
10.4.3.
United Kingdom Lung Cancer Genomic Testing
Market Outlook
10.4.3.1.
Market Size & Forecast
10.4.3.1.1.
By Value
10.4.3.2.
Market Share & Forecast
10.4.3.2.1.
By Component
10.4.3.2.2.
By Technology
10.4.3.2.3.
By Panel Type
10.4.3.2.4.
By Sample Type
10.4.3.2.5.
By End User
10.4.4.
Italy Lung Cancer Genomic Testing Market Outlook
10.4.4.1.
Market Size & Forecast
10.4.4.1.1.
By Value
10.4.4.2.
Market Share & Forecast
10.4.4.2.1.
By Component
10.4.4.2.2.
By Technology
10.4.4.2.3.
By Panel Type
10.4.4.2.4.
By Sample Type
10.4.4.2.5.
By End User
10.4.5.
Spain Lung Cancer Genomic Testing Market Outlook
10.4.5.1.
Market Size & Forecast
10.4.5.1.1.
By Value
10.4.5.2.
Market Share & Forecast
10.4.5.2.1.
By Component
10.4.5.2.2.
By Technology
10.4.5.2.3.
By Panel Type
10.4.5.2.4.
By Sample Type
10.4.5.2.5.
By End User
10.4.6.
Denmark Lung Cancer Genomic Testing Market Outlook
10.4.6.1.
Market Size & Forecast
10.4.6.1.1.
By Value
10.4.6.2.
Market Share & Forecast
10.4.6.2.1.
By Component
10.4.6.2.2.
By Technology
10.4.6.2.3.
By Panel Type
10.4.6.2.4.
By Sample Type
10.4.6.2.5.
By End User
10.4.7.
Netherlands Lung Cancer Genomic Testing Market Outlook
10.4.7.1.
Market Size & Forecast
10.4.7.1.1.
By Value
10.4.7.2.
Market Share & Forecast
10.4.7.2.1.
By Component
10.4.7.2.2.
By Technology
10.4.7.2.3.
By Panel Type
10.4.7.2.4.
By Sample Type
10.4.7.2.5.
By End User
11. Asia-Pacific Lung
Cancer Genomic Testing Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Component
11.2.2.
By Technology
11.2.3.
By Panel Type
11.2.4.
By Sample Type
11.2.5.
By End User
11.2.6.
By Country
11.3.
Policy & Regulatory Landscape
11.4.
Asia-Pacific: Country Analysis
11.4.1.
China Lung Cancer Genomic Testing Market Outlook
11.4.1.1.
Market Size & Forecast
11.4.1.1.1.
By Value
11.4.1.2.
Market Share & Forecast
11.4.1.2.1.
By Component
11.4.1.2.2.
By Technology
11.4.1.2.3.
By Panel Type
11.4.1.2.4.
By Sample Type
11.4.1.2.5.
By End User
11.4.2.
India Lung Cancer Genomic Testing Market Outlook
11.4.2.1.
Market Size & Forecast
11.4.2.1.1.
By Value
11.4.2.2.
Market Share & Forecast
11.4.2.2.1.
By Component
11.4.2.2.2.
By Technology
11.4.2.2.3.
By Panel Type
11.4.2.2.4.
By Sample Type
11.4.2.2.5.
By End User
11.4.3.
South Korea Lung Cancer Genomic Testing
Market Outlook
11.4.3.1.
Market Size & Forecast
11.4.3.1.1.
By Value
11.4.3.2.
Market Share & Forecast
11.4.3.2.1.
By Component
11.4.3.2.2.
By Technology
11.4.3.2.3.
By Panel Type
11.4.3.2.4.
By Sample Type
11.4.3.2.5.
By End User
11.4.4.
Japan Lung Cancer Genomic Testing Market Outlook
11.4.4.1.
Market Size & Forecast
11.4.4.1.1.
By Value
11.4.4.2.
Market Share & Forecast
11.4.4.2.1.
By Component
11.4.4.2.2.
By Technology
11.4.4.2.3.
By Panel Type
11.4.4.2.4.
By Sample Type
11.4.4.2.5.
By End User
11.4.5.
Australia Lung Cancer Genomic Testing Market Outlook
11.4.5.1.
Market Size & Forecast
11.4.5.1.1.
By Value
11.4.5.2.
Market Share & Forecast
11.4.5.2.1.
By Component
11.4.5.2.2.
By Technology
11.4.5.2.3.
By Panel Type
11.4.5.2.4.
By Sample Type
11.4.5.2.5.
By End User
12. South America Lung
Cancer Genomic Testing Market Outlook
12.1.
Market Size & Forecast
12.1.1.
By Value
12.2.
Market Share & Forecast
12.2.1.
By Component
12.2.2.
By Technology
12.2.3.
By Panel Type
12.2.4.
By Sample Type
12.2.5.
By End User
12.2.6.
By Country
12.3.
Policy & Regulatory Landscape
12.4.
South America: Country Analysis
12.4.1.
Brazil Lung Cancer Genomic Testing Market Outlook
12.4.1.1.
Market Size & Forecast
12.4.1.1.1.
By Value
12.4.1.2.
Market Share & Forecast
12.4.1.2.1.
By Component
12.4.1.2.2.
By Technology
12.4.1.2.3.
By Panel Type
12.4.1.2.4.
By Sample Type
12.4.1.2.5.
By End User
12.4.2.
Argentina Lung Cancer Genomic Testing Market Outlook
12.4.2.1.
Market Size & Forecast
12.4.2.1.1.
By Value
12.4.2.2.
Market Share & Forecast
12.4.2.2.1.
By Component
12.4.2.2.2.
By Technology
12.4.2.2.3.
By Panel Type
12.4.2.2.4.
By Sample Type
12.4.2.2.5.
By End User
12.4.3.
Colombia Lung Cancer Genomic Testing Market Outlook
12.4.3.1.
Market Size & Forecast
12.4.3.1.1.
By Value
12.4.3.2.
Market Share & Forecast
12.4.3.2.1.
By Component
12.4.3.2.2.
By Technology
12.4.3.2.3.
By Panel Type
12.4.3.2.4.
By Sample Type
12.4.3.2.5.
By End User
13. Middle East and
Africa Lung Cancer Genomic Testing Market Outlook
13.1.
Market Size & Forecast
13.1.1.
By Value
13.2.
Market Share & Forecast
13.2.1.
By Component
13.2.2.
By Technology
13.2.3.
By Panel Type
13.2.4.
By Sample Type
13.2.5.
By End User
13.2.6.
By Country
13.3.
Policy & Regulatory Landscape
13.4.
MEA: Country Analysis
13.4.1.
Turkey Lung Cancer Genomic Testing Market Outlook
13.4.1.1.
Market Size & Forecast
13.4.1.1.1.
By Value
13.4.1.2.
Market Share & Forecast
13.4.1.2.1.
By Component
13.4.1.2.2.
By Technology
13.4.1.2.3.
By Panel Type
13.4.1.2.4.
By Sample Type
13.4.1.2.5.
By End User
13.4.2.
South Africa Lung Cancer Genomic Testing
Market Outlook
13.4.2.1.
Market Size & Forecast
13.4.2.1.1.
By Value
13.4.2.2.
Market Share & Forecast
13.4.2.2.1.
By Component
13.4.2.2.2.
By Technology
13.4.2.2.3.
By Panel Type
13.4.2.2.4.
By Sample Type
13.4.2.2.5.
By End User
13.4.3.
Saudi Arabia Lung Cancer Genomic Testing
Market Outlook
13.4.3.1.
Market Size & Forecast
13.4.3.1.1.
By Value
13.4.3.2.
Market Share & Forecast
13.4.3.2.1.
By Component
13.4.3.2.2.
By Technology
13.4.3.2.3.
By Panel Type
13.4.3.2.4.
By Sample Type
13.4.3.2.5.
By End User
13.4.4.
UAE Lung Cancer Genomic Testing Market Outlook
13.4.4.1.
Market Size & Forecast
13.4.4.1.1.
By Value
13.4.4.2.
Market Share & Forecast
13.4.4.2.1.
By Component
13.4.4.2.2.
By Technology
13.4.4.2.3.
By Panel Type
13.4.4.2.4.
By Sample Type
13.4.4.2.5.
By End User
14.
Market Dynamics
14.1.
Drivers
14.2.
Challenges
15.
Market Trends & Developments
16.
SWOT Analysis: Global Lung Cancer Genomic Testing Market
17.
Competitive Landscape (Inclusive of SWOT Analysis of
Players Profiled)
17.1.
Qiagen NV
17.2.
Agilent Technologies, Inc.
17.3.
Thermo Fischer Scientific, Inc.
17.4.
Quest Diagnostics, Inc.
17.5.
Laboratory Corporation of America Holdings
17.6.
Centogene N.V.
17.7.
CeGaT GmbH
17.8.
Illumina, Inc.
17.9.
F. Hoffmann-La Roche AG
17.10.
Abbott Laboratories, Inc.
17.11.
CD Genomics
17.12.
NeoGenomics Laboratories
17.13.
OPKO Health, Inc.
17.14.
OncoDNA
17.15.
Admera Health
18. Strategic Recommendations